ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)
CUSIP: 488445206
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 56,066,823
- Total 13F shares
- 38,146,946
- Share change
- -1,761,878
- Total reported value
- $341,787,064
- Put/Call ratio
- 65%
- Price per share
- $8.96
- Number of holders
- 158
- Value change
- -$17,167,999
- Number of buys
- 79
- Number of sells
- 80
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
4,037,154
|
$38,393,334 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
13D/G
|
Company |
6.2%
from 13D/G
|
3,476,143
|
$33,058,120 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
3,083,362
|
$29,322,773 | — | 30 Sep 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
4%
|
2,225,000
|
$21,159,750 | -$13,551,750 | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4%
|
2,225,000
|
$21,159,750 | — | 30 Sep 2025 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
1,971,936
|
$18,753,112 | — | 30 Sep 2025 | |
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| FMR LLC |
13F
|
Company |
2.9%
|
1,634,571
|
$15,544,766 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
1,427,291
|
$13,573,537 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,300,340
|
$12,368,921 | — | 30 Sep 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
2.2%
|
1,231,932
|
$11,715,673 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
2.2%
|
1,205,514
|
$11,464,438 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
1.9%
|
1,053,399
|
$10,017,824 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,035,251
|
$9,845,237 | — | 30 Sep 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.7%
|
975,000
|
$9,272,250 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.6%
|
912,299
|
$8,675,963 | — | 30 Sep 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.4%
|
810,000
|
$7,703,100 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
761,777
|
$7,244,500 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.3%
|
725,830
|
$6,902,644 | — | 30 Sep 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.2%
|
691,239
|
$6,573,683 | — | 30 Sep 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.2%
|
650,000
|
$6,181,500 | — | 30 Sep 2025 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
1.1%
|
600,770
|
$5,713,323 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.99%
|
555,950
|
$5,287,085 | — | 30 Sep 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.91%
|
510,091
|
$4,850,965 | — | 30 Sep 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.8%
|
447,896
|
$4,259,491 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.78%
|
439,480
|
$4,179,455 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.78%
|
438,984
|
$4,174,739 | — | 30 Sep 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.75%
|
418,550
|
$3,980,000 | — | 30 Sep 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.74%
|
412,547
|
$3,935,698 | — | 30 Sep 2025 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.62%
|
346,652
|
$3,296,661 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.59%
|
332,443
|
$3,161,534 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.55%
|
306,489
|
$2,914,710 | — | 30 Sep 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.54%
|
302,863
|
$2,880,227 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
288,045
|
$2,739,308 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.48%
|
268,077
|
$2,549,412 | — | 30 Sep 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.41%
|
231,874
|
$2,205,122 | — | 30 Sep 2025 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.41%
|
229,000
|
$2,177,790 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
218,096
|
$2,074,093 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.38%
|
214,202
|
$2,037,061 | — | 30 Sep 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.35%
|
193,509
|
$1,840,271 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.34%
|
191,796
|
$1,823,980 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.33%
|
187,266
|
$1,780,900 | — | 30 Sep 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.33%
|
183,701
|
$1,747,000 | — | 30 Sep 2025 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.31%
|
175,283
|
$1,666,939 | — | 30 Sep 2025 | |
| R. LaDuane Clifton |
3/4/5
|
Former CFO & Treasurer |
—
mixed-class rows
|
211,515
mixed-class rows
|
$1,555,014 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
157,765
|
$1,500,345 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.27%
|
153,032
|
$1,455,334 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
152,311
|
$1,448,478 | — | 30 Sep 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.26%
|
147,000
|
$1,397,970 | — | 30 Sep 2025 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.23%
|
130,751
|
$1,243,442 | — | 30 Sep 2025 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q4 2025
As of 31 Dec 2025,
ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,146,946 shares.
The largest 10 holders included
BlackRock, Inc., Woodline Partners LP, VANGUARD GROUP INC, FMR LLC, Nantahala Capital Management, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and Legal & General Group Plc.
This page lists
158
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
164
Q4 2025 holders
158
Holder diff
-6
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.